Literature DB >> 3496023

Comparison of etomidate and propofol for anaesthesia in microlaryngeal surgery.

P M de Grood, S Mitsukuri, J van Egmond, J M Rutten, J F Crul.   

Abstract

Propofol and etomidate were compared as hypnotics in total intravenous anaesthesia for microlaryngeal surgery combined with jet ventilation. Two groups of 15 patients were studied. In group 1, propofol 2.0 mg/kg was used for induction. For maintenance a continuous infusion of 12 mg/kg/hour was used for the first 10 minutes, followed by 9 mg/kg/hour for the next 10 minutes and 6 mg/kg/hour thereafter. In group 2, the induction dose of etomidate was 0.3 mg/kg followed by continuous infusion of 1.8 mg/kg/hour for 10 minutes, 1.5 mg/kg/hour for the next 10 minutes and 1.0 mg/kg/hour thereafter. Alfentanil was given for analgesia and suxamethonium for muscle relaxation. The propofol group showed better surgical conditions, more stable anaesthesia and better recovery according to the Steward score. Recovery times to opening eyes on command were comparable for both groups.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3496023     DOI: 10.1111/j.1365-2044.1987.tb03976.x

Source DB:  PubMed          Journal:  Anaesthesia        ISSN: 0003-2409            Impact factor:   6.955


  3 in total

Review 1.  Propofol. A review of its pharmacodynamic and pharmacokinetic properties and use as an intravenous anaesthetic.

Authors:  M S Langley; R C Heel
Journal:  Drugs       Date:  1988-04       Impact factor: 9.546

2.  Effect of sevoflurane versus propofol-based anesthesia on the hemodynamic response and recovery characteristics in patients undergoing microlaryngeal surgery.

Authors:  Neerja Bharti; Promila Chari; Parag Kumar
Journal:  Saudi J Anaesth       Date:  2012 Oct-Dec

3.  Evaluation of bispectral index monitoring efficacy in endoscopic patients who underwent retrograde cholangiopancreatography and received sedoanalgesia.

Authors:  Ferda Yilmaz Inal; Hayrettin Daskaya; Yadigar Yilmaz; Hasan Kocoglu
Journal:  Wideochir Inne Tech Maloinwazyjne       Date:  2020-03-04       Impact factor: 1.195

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.